Lipitor Holds Up In Merger Dispute; Warner-Lambert, Pfizer Beat Expectations

Warner-Lambert's Lipitor is showing no signs of a negative impact from the distractions caused by the hostile takeover bid launched by Warner's marketing partner Pfizer.